LYRA Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
LYRA Therapeutics Inc
TickerLYRA
CIK #0001327273
CUSIP55234L105
SectorLife Sciences - Surgical & Medical Instruments & Apparatus
Address480 Arsenal Street, Watertown, MA 02472
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
LYRA Therapeutics Inc 2023-06-09 50.0 M Exemption: 506(b) · Duration: One year or less · Commission: $3,100,000 · Revenue: Decline to Disclose
480 Biomedical Inc 2016-11-28 6.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Arsenal Vascular Inc 2011-11-08 3.0 M Exemption: 506 · Duration: One year or less · Revenue: Decline to Disclose
Arsenal Medical Inc 2010-08-12 3.0 M Exemption: 506 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001327273] 10-K
[0001327273] 10-Q
[0001327273] 3
[0001327273] 4
[0001327273] 8-K
[0001327273] D
[0001327273] SC 13D
[0001327273] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Sabby Management LLC LYRA Therapeutics Inc [2026-01-20] 0.0
Vestal Point Capital LP LYRA Therapeutics Inc [2024-02-13] 5.7
Point72 Asset Management LP LYRA Therapeutics Inc [2023-11-16] 5.4
Samsara Biocapital LP LYRA Therapeutics Inc [2023-08-25] 5.6
Citadel Advisors LLC LYRA Therapeutics Inc [2023-06-12] 5.8
Nantahala Capital Management LLC LYRA Therapeutics Inc [2023-02-14] 7.0
Pura Vida Investments LLC LYRA Therapeutics Inc [2022-11-08] 8.74
Venrock Healthcare Capital Partners II LP LYRA Therapeutics Inc [2022-04-22] 0.999
RA Capital Management LP LYRA Therapeutics Inc [2021-02-16] 6.3
ArrowMark Colorado Holdings LLC LYRA Therapeutics Inc [2021-02-16] 5.0
Polaris Venture Partners V LP LYRA Therapeutics Inc [2021-02-12] 8.2
Intersouth Partners VII L P LYRA Therapeutics Inc [2021-02-12] 5.7
Ikarian Capital LLC LYRA Therapeutics Inc [2020-12-30] 6.1
Perceptive Advisors LLC LYRA Therapeutics Inc [2020-06-01] 24.9
NBVM GP LLC LYRA Therapeutics Inc [2020-05-15] 11.0
Form 3/4/5 Filer 2011 - 2026
Smith W Bradford
Lyra Therapeutics Inc
Palasis Maria
Cavalier Jason
Perceptive Advisors LLC
Perceptive LS A LLC
Edelman Joseph
Perceptive Life Sciences Master Fund Ltd
snyderman nancy lynn MD
Tobin James R
Merrifield C Ann
Waksal Harlan
Altman Michael Seth
Poukalov Konstantin
Nieman Richard
Bishop John E
Anderson Edward T
North Bridge Venture Partners V A LP
North Bridge Venture Management VI LP
NBVM GP LLC
North Bridge Venture Management V LP
North Bridge Venture Partners VI L P
North Bridge Venture Partners V-B LP
Damore Richard A
Richard Robert E
Noyes Corinne
Nelson Pamela E
Elsey R Don
Soleus PE GP I LLC
Soleus Private Equity GP I LLC
Levy Guy
Soleus Private Equity Fund I LP
Soleus Capital Master Fund LP
Soleus Capital LLC
Soleus Capital Group LLC
Whitesides George M
Polaris Venture Partners IV LP
Polaris Venture Partners Entrepreneurs Fund IV LP
Polaris Venture Management Co IV LLC
Roberts Carmichael
Langer Robert
McGuire Terrance
Polaris Venture Partners V LP
Polaris Venture Partners Entrepreneurs' Fund V LP
Polaris Venture Management Co V LLC
Flint Jonathan A
Polaris Venture Partners Founders' Fund V LP
Polaris Venture Partners Special Founders' Fund V LP
Edgerly-Pflug Laura
Mott Richard W
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Cavalier Jason
Common Stock
2026-01-06 Sell 769 $3.36 2,584
Palasis Maria
Common Stock
2026-01-06 Sell 1,702 $3.36 5,719
Perceptive Advisors LLC +3
Common Stock
2025-11-13 Sell 3,213 $3.90 12,531
Perceptive Advisors LLC +3
Common Stock
2025-11-13 Sell 28,597 $3.90 111,528
Perceptive Advisors LLC +3
Common Stock
2025-11-12 Sell 7,862 $4.06 31,920
Perceptive Advisors LLC +3
Common Stock
2025-11-12 Sell 883 $4.06 3,585
Perceptive Advisors LLC +3
Common Stock
2025-11-11 Sell 4,783 $4.31 20,615
Perceptive Advisors LLC +3
Common Stock
2025-11-11 Sell 537 $4.31 2,314
Perceptive Advisors LLC +3
Common Stock
2025-11-10 Sell 1,869 $4.54 8,485
Perceptive Advisors LLC +3
Common Stock
2025-11-10 Sell 16,633 $4.54 75,514
Perceptive Advisors LLC +3
Common Stock
2025-11-07 Sell 17,746 $4.75 84,294
Perceptive Advisors LLC +3
Common Stock
2025-11-07 Sell 1,993 $4.75 9,467
Perceptive Advisors LLC +3
Common Stock
2025-11-06 Sell 28,902 $5.18 149,712
Perceptive Advisors LLC +3
Common Stock
2025-11-06 Sell 3,247 $5.18 16,819
Palasis Maria
Employee Stock Option (right to buy) · derivative
2025-10-01 Grant 3,667 $0.00
Cavalier Jason
Common Stock
2025-07-10 Sell 684 $8.91 6,094
Palasis Maria
Common Stock
2025-07-10 Sell 1,565 $8.91 13,944
snyderman nancy lynn MD
Restricted Stock Units · derivative
2025-05-14 Grant 32,000 $0.00
Smith W Bradford
Restricted Stock Units · derivative
2025-05-14 Grant 32,000 $0.00
Merrifield C Ann
Restricted Stock Units · derivative
2025-05-14 Grant 32,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 1 104,059
2025-12-31 23 242,640
2025-09-30 26 448,639
2025-06-30 31 495,151
2025-03-31 59 25,686,874
2024-12-31 56 26,908,083
2024-09-30 63 32,613,208
2024-06-30 53 33,087,207
2024-03-31 81 46,005,306
2023-12-31 62 46,685,831
2023-09-30 46 32,177,023
2023-06-30 40 33,942,900
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com